先进的糖化终端产品在糖尿病并发症中激活了基马酶依赖的血管新生素II生成途径
Vijay Koka1, Wansheng Wang, Xiao Ru Huang
1Department of Medicine-Nephrology, Baylor College of Medicine, Houston, TX 77030, USA.
Circulation
|March 8, 2006
概括
先进的糖化终产物 (AGEs) 通过RAGE-ERK1/2通路诱导糖尿病中的基马酶. 这种化学酶对血管素II的产生有显著的贡献,在糖尿病血管疾病中发挥着关键作用.
科学领域:
- 血管生物学 血管生物学
- 糖尿病并发症 糖尿病并发症
- 酶学 是一种酶学.
背景情况:
- ангиотензин II 是糖尿病相关血管疾病的关键调解剂.
- 基马酶是高血压和糖尿病的另一种血管素II生成酶,但其在糖尿病中的诱导机制尚不清楚.
研究的目的:
- 研究糖尿病血管疾病中基马酶诱导的机制.
主要方法:
- 免疫组织化学检测糖尿病患者动脉中的基酶上调.
- 在体外研究中,使用暴露于AGE的人类血管光滑肌细胞.
- RAGE抗体中和ERK1/2通路抑制的实验.
主要成果:
- 在糖尿病患者的冠状动脉和脏动脉中,基马酶被上调.
- 先进的糖化终产物 (AGEs) 通过RAGE-ERK1/2 MAP激酶通路诱导基酶表达.
- 化学酶占AGE诱导的血管新生素II生成的70%以上.
结论:
- 在糖尿病中,AGE通过RAGE-ERK1/2 MAP激酶途径诱导基马酶.
- 基马酶代表了糖尿病血管疾病中血管素II生成的重要替代途径.
相关概念视频
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...


